Login / Signup

Identifying putative cerebrospinal fluid biomarkers of amyotrophic lateral sclerosis in a north Indian population.

Radhika KhoslaManjari RainShreyas ChawatheyShweta ModgilRahul TyagiKeshav ThakurViraaj PannuSuresh Kumar SharmaAkshay Anand
Published in: Muscle & nerve (2020)
Our findings suggest possible utility of VEGF, VEGFR2, and ANG as biomarkers for use in ALS treatment trials.
Keyphrases
  • amyotrophic lateral sclerosis
  • cerebrospinal fluid
  • vascular endothelial growth factor